tm logo

Monitor this mark

View On USPTO

NIVAGEN
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 21 Feb 2024

Last Applicant/ Owned by

Nivagen Pharmaceuticals, Inc.

3100 Fite Circle

Sacramento

CA

95827

Serial Number

87451155 filed on 16th May 2017

Registration Number

5354876 registered on 12th Dec 2017

in the Principal Register

Correspondent Address

Ted Whitlock

Ted Whitlock

5323 SW 38TH AVENUE

FORT LAUDERDALE,FL 33312

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

NIVAGEN

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development

First Use Date in General

31st Jan 2015

First Use Date in Commerce

31st Jan 2015

Mark Details

Serial Number

No 87451155

Mark Type

No Service Mark

Attorney Docket Number

No NVG-3106SM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
21st Feb 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
21st Feb 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20th Feb 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31st Aug 2023TEAS SECTION 8 & 15 RECEIVED
12th Dec 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12th Dec 2017REGISTERED-PRINCIPAL REGISTER
26th Sep 2017PUBLISHED FOR OPPOSITION
26th Sep 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06th Sep 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15th Aug 2017ASSIGNED TO EXAMINER